EFMC-ACSMEDI Medicinal Chemistry Frontiers 2024

In person

From 8 to 11 April Johan Veerman and Gregg Siegal attended ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium. The EFMC | ACSMEDI Medicinal Chemistry Frontiers is co-organized as a collaboration between the EFMC, European Federation for Medicinal Chemistry and Chemical Biology, and ACS MEDI, the division of Medicinal Chemistry of the American Chemical Society. The 2024 edition took place in Utrecht, NL, together with the Section for Medicinal Chemistry and Chemical Biology of KNCV.

The meeting attracted a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.

On Tuesday, April 9th Johan Veerman had an opportunity to present the lecture: The Art of Crafting a Mode of Action: Site Selective Hit Discovery.